4.6 Article

Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma

Tomonari Shimagaki et al.

Summary: Early recurrence (ER) of pancreatic ductal adenocarcinoma (PDAC) after resection can be predicted by calculating a score using preoperative serum CA19-9 concentration, platelet-to-lymphocyte ratio (PLR), and tumor diameter. The prediction model has high sensitivity and specificity.

PLOS ONE (2023)

Review Medicine, General & Internal

Statins Are Associated with Improved Survival of Patients with Gastric Cancer: A Systematic Review and Meta-Analysis

Mingjie Yuan et al.

Summary: Statins have shown to improve overall survival in gastric cancer treatment, with the benefit mainly observed in retrospective studies rather than prospective studies.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2022)

Article Oncology

Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence?

Domenico Tamburrino et al.

Summary: The study found that chronic use of aspirin is associated with increased DFS but not with better DSS after surgical resection in patients with PDAC. Additionally, metformin also had an impact on DFS.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Oncology

Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway

Nathalie C. Stoer et al.

Summary: The study investigates the association between the use of certain drugs and cancer-specific mortality in pancreatic cancer patients. It suggests that statins and non-selective beta-blockers may be associated with reduced pancreatic cancer mortality, supporting the need for randomized clinical trials to further evaluate their potential in pancreatic cancer management.

ACTA ONCOLOGICA (2021)

Review Gastroenterology & Hepatology

Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis

Domenico Tamburrino et al.

DIGESTIVE AND LIVER DISEASE (2020)

Review Chemistry, Multidisciplinary

The Innovative Potential of Statins in Cancer: New Targets for New Therapies

Elisabetta Di Bello et al.

FRONTIERS IN CHEMISTRY (2020)

Review Gastroenterology & Hepatology

Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis

Livia Archibugi et al.

DIGESTIVE AND LIVER DISEASE (2019)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Public, Environmental & Occupational Health

Danish Pancreatic Cancer Database

Claus Fristrup et al.

CLINICAL EPIDEMIOLOGY (2016)